LOTRIMIN AF Miconazole Nitrate Powder Spray Recall for Benzene Contamination
Bayer Healthcare Pharmaceuticals is recalling LOTRIMIN AF Jock Itch Powder Spray (4.6 oz, Miconazole Nitrate 2%) because certain lots contain benzene, a chemical contaminant.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The FDA has classified this recall as Class I, which per the rubric requires a minimum score of 4. The presence of benzene—a known carcinogen—in a topical drug product represents a serious health hazard requiring immediate action.
Plain-English summary
Bayer Healthcare Pharmaceuticals Inc. is recalling LOTRIMIN AF Jock Itch Powder Spray containing Miconazole Nitrate 2% in 133g (4.6 oz) cans. The product has been identified as containing benzene, a chemical contaminant.
The affected product was distributed nationwide in the United States, Puerto Rico, Canada, and Mexico through various retail channels. The affected lot numbers are CV018TV (expiration 11/30/2021), CV01A71 (1/31/2022), CV01CK4 (4/30/2022), TN0023G (12/31/2022), TN006TC (1/31/2023), TN007TG (3/31/2023), TN008CZ (4/30/2023), and TN008CY (4/30/2023).
Consumers who have purchased this product should stop using it immediately. Those with questions or concerns should contact their healthcare provider. The product is distributed by Bayer Healthcare LLC in Whippany, New Jersey (NDC 11523-4140-2, UPC 3 11017 41031 8).
The recalled product
- Product
- LOTRIMIN AF, (Miconazole nitrate 2%), Jock Itch, Powder Spray, NET WT 133g (4.6 OZ) can, Dist by: Bayer Healthcare LLC, Whippany, NJ 07981, Product of Spain, NDC 11523-4140-2. UPC 3 11017 41031 8
- Manufacturer
- Bayer Healthcare Pharmaceuticals Inc.
- Category
- Drug — Topical Antifungal
- Hazard
- chemical-contamination-benzene
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (16)
- Lot # CV018TV
- 11/30/2021
- CV01A71
- 1/31/2022
- CV01CK4
- 4/30/2022
- TN0023G
- 12/31/2022
- TN006TC
- 1/31/2023
- TN007TG
- 3/31/2023
- TN008CZ
- 4/30/2023
- TN008CY
- 4/30/2023.
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- HighBeak & Skiff Alcohol Antiseptic Sanitizer recalled for acetaldehyde contamination
FDA (Drugs) · 2026-06-17
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27